Antibody-drug conjugates
These companies develop cancer drugs that use antibodies to carry a toxic payload straight to target cells.
−9.2%
over 1 year · S&P 500 +11.6%
Key indicators
Health
46 / 100
Fragile
Solid
Up over 1 year
5 of 12
Volatility
81%
Calm
Choppy
Profitability
−395%
Low
High
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 12 companies
IDYA
−0.4%
IMNM
+7.7%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
I
IDEAYA Biosciences
IDYA
42.1%
−0.4%
I
Immunome
IMNM
31.1%
+7.7%
A
ArriVent BioPharma
AVBP
9.1%
−35.6%
C
Crescent Biopharma
CBIO
7.1%
+8.4%
C
CytomX Therapeutics
CTMX
6.3%
−51.8%
S
Sutro Biopharma
STRO
2.2%
+21.1%
A
ALX Oncology
ALXO
2.2%
−18.8%
B
BioAtla
BCAB
<0.1%
−95.0%
A
ADC Therapeutics
ADCT
−66.9%
B
BioNTech
BNTX
−23.4%
G
Genmab
GMAB
+68.6%
Z
Zai Lab
ZLAB
+12.4%